Tag: lung cancer


Health Canada Approves Alecensaro to Treat Rare Lung Cancer

Health Canada has approved Alecensaro (alectinib) to treat patients with a rare form of lung cancer. The drug is approved as a  first-line monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive locally advanced (not amenable to curative therapy) or metastatic non-small cell lung cancer (NSCLC).

Read More